annual EBITDA:
-$173.33M-$47.50M(-37.75%)Summary
- As of today (September 13, 2025), KALV annual EBITDA is -$173.33 million, with the most recent change of -$47.50 million (-37.75%) on April 30, 2025.
- During the last 3 years, KALV annual EBITDA has fallen by -$92.58 million (-114.66%).
- KALV annual EBITDA is now -9753.67% below its all-time high of -$1.76 million, reached on December 31, 2012.
Performance
KALV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$58.76M-$3.99M(-7.28%)Summary
- As of today (September 13, 2025), KALV quarterly EBITDA is -$58.76 million, with the most recent change of -$3.99 million (-7.28%) on July 31, 2025.
- Over the past year, KALV quarterly EBITDA has dropped by -$14.77 million (-33.57%).
- KALV quarterly EBITDA is now -5340.46% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
KALV quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$201.82M-$14.77M(-7.89%)Summary
- As of today (September 13, 2025), KALV TTM EBITDA is -$201.82 million, with the most recent change of -$14.77 million (-7.89%) on July 31, 2025.
- Over the past year, KALV TTM EBITDA has dropped by -$47.10 million (-30.44%).
- KALV TTM EBITDA is now -11702.40% below its all-time high of -$1.71 million, reached on September 1, 2013.
Performance
KALV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KALV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.8% | -33.6% | -30.4% |
| 3 y3 years | -114.7% | -124.6% | -96.6% |
| 5 y5 years | -333.1% | -310.7% | -348.4% |
KALV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -114.7% | at low | -128.7% | at low | -96.6% | at low |
| 5 y | 5-year | -333.1% | at low | -369.6% | at low | -348.4% | at low |
| alltime | all time | -9753.7% | at low | -5340.5% | at low | <-9999.0% | at low |
KALV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jul 2025 | - | -$58.76M(+7.3%) | -$201.82M(+7.9%) |
| Apr 2025 | -$173.33M(+37.7%) | -$54.77M(+28.2%) | -$187.06M(+3.6%) |
| Jan 2025 | - | -$42.71M(-6.3%) | -$180.52M(+5.7%) |
| Oct 2024 | - | -$45.58M(+3.6%) | -$170.75M(+10.4%) |
| Jul 2024 | - | -$43.99M(-8.8%) | -$154.72M(+10.8%) |
| Apr 2024 | -$125.83M(+33.3%) | -$48.24M(+46.4%) | -$139.62M(+13.7%) |
| Jan 2024 | - | -$32.94M(+11.5%) | -$122.79M(+5.3%) |
| Oct 2023 | - | -$29.55M(+2.3%) | -$116.58M(+3.4%) |
| Jul 2023 | - | -$28.89M(-8.0%) | -$112.72M(+2.5%) |
| Apr 2023 | -$94.37M(+16.9%) | -$31.40M(+17.5%) | -$109.99M(+4.5%) |
| Jan 2023 | - | -$26.74M(+4.1%) | -$105.21M(+0.3%) |
| Oct 2022 | - | -$25.69M(-1.8%) | -$104.91M(+2.2%) |
| Jul 2022 | - | -$26.16M(-1.8%) | -$102.67M(+7.1%) |
| Apr 2022 | - | -$26.63M(+0.8%) | -$95.87M(+10.1%) |
| Apr 2022 | -$80.75M(+40.7%) | - | - |
| Jan 2022 | - | -$26.43M(+12.7%) | -$87.05M(+19.0%) |
| Oct 2021 | - | -$23.45M(+21.1%) | -$73.14M(+17.3%) |
| Jul 2021 | - | -$19.36M(+8.7%) | -$62.33M(+8.8%) |
| Apr 2021 | -$57.39M(+43.4%) | -$17.81M(+42.4%) | -$57.27M(+17.6%) |
| Jan 2021 | - | -$12.51M(-1.0%) | -$48.69M(+0.1%) |
| Oct 2020 | - | -$12.64M(-11.7%) | -$48.62M(+8.0%) |
| Jul 2020 | - | -$14.31M(+55.0%) | -$45.01M(+12.5%) |
| Apr 2020 | -$40.02M | -$9.23M(-25.8%) | -$40.01M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2020 | - | -$12.45M(+37.9%) | -$41.91M(+16.3%) |
| Oct 2019 | - | -$9.03M(-3.0%) | -$36.03M(+13.3%) |
| Jul 2019 | - | -$9.30M(-16.5%) | -$31.79M(+8.0%) |
| Apr 2019 | -$29.44M(+58.9%) | -$11.14M(+69.9%) | -$29.44M(+38.7%) |
| Jan 2019 | - | -$6.56M(+36.9%) | -$21.22M(+11.9%) |
| Oct 2018 | - | -$4.79M(-31.2%) | -$18.96M(-5.5%) |
| Jul 2018 | - | -$6.96M(+138.5%) | -$20.06M(+8.3%) |
| Apr 2018 | -$18.52M(-16.9%) | -$2.92M(-32.1%) | -$18.52M(-10.4%) |
| Jan 2018 | - | -$4.30M(-27.1%) | -$20.68M(+26.2%) |
| Oct 2017 | - | -$5.89M(+8.7%) | -$16.39M(+56.1%) |
| Jul 2017 | - | -$5.42M(+6.8%) | -$10.50M(+106.8%) |
| Apr 2017 | -$22.30M(-5.2%) | -$5.08M(-8.3%) | -$5.08M(-75.7%) |
| Dec 2015 | -$23.52M(+92.5%) | -$5.53M(+13.7%) | -$20.90M(+9.0%) |
| Sep 2015 | - | -$4.87M(-13.6%) | -$19.17M(+7.4%) |
| Jun 2015 | - | -$5.63M(+15.7%) | -$17.85M(+21.9%) |
| Mar 2015 | - | -$4.87M(+28.1%) | -$14.65M(+26.0%) |
| Dec 2014 | -$12.22M(+133.0%) | -$3.80M(+7.1%) | -$11.62M(+30.6%) |
| Sep 2014 | - | -$3.55M(+46.3%) | -$8.90M(+26.1%) |
| Jun 2014 | - | -$2.43M(+31.4%) | -$7.06M(+52.3%) |
| Mar 2014 | - | -$1.85M(+70.9%) | -$4.64M(+66.2%) |
| Dec 2013 | -$5.25M(+198.2%) | -$1.08M(-36.8%) | -$2.79M(+63.2%) |
| Sep 2013 | - | -$1.71M | -$1.71M |
| Dec 2012 | -$1.76M | - | - |
FAQ
- What is KalVista Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for KalVista Pharmaceuticals, Inc.?
- What is KalVista Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is KalVista Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for KalVista Pharmaceuticals, Inc.?
- What is KalVista Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is KalVista Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for KalVista Pharmaceuticals, Inc.?
- What is KalVista Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is KalVista Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of KALV is -$173.33M
What is the all time high annual EBITDA for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high annual EBITDA is -$1.76M
What is KalVista Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, KALV annual EBITDA has changed by -$47.50M (-37.75%)
What is KalVista Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of KALV is -$58.76M
What is the all time high quarterly EBITDA for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$1.08M
What is KalVista Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, KALV quarterly EBITDA has changed by -$14.77M (-33.57%)
What is KalVista Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of KALV is -$201.82M
What is the all time high TTM EBITDA for KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. all-time high TTM EBITDA is -$1.71M
What is KalVista Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, KALV TTM EBITDA has changed by -$47.10M (-30.44%)